Targeting the Non-Canonical NF-?B Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma. (2022)

First Author: Burley TA
Attributed to:  Overcoming Ibrutinib and Venetoclax resistance in Chronic Lymphocytic Leukaemia. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers14061489

PubMed Identifier: 35326640

Publication URI: http://europepmc.org/abstract/MED/35326640

Type: Journal Article/Review

Volume: 14

Parent Publication: Cancers

Issue: 6

ISSN: 2072-6694